跳至主要内容
临床试验/CTRI/2025/04/085843
CTRI/2025/04/085843尚未招募4 期

Efficacy of Intratympanic Dexamethasone and Oral Deflazacort in Sudden Sensorineural Hearing Loss- A Randomized Single Blind Trial

DR LIPSY1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年5月10日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
To compare the improvement of hearing by intratympanic dexamethasone versus oral deflazacort in sudden sensorineural hearing loss (SSNHL).

研究概览

简要总结

There is a need to find the comparison between the intratympanic dexamethasone and oral deflazacort in the treatment of sudden sensorineural hearing loss because sudden sensorineural hearing loss (SNHL) is a emergency condition.

•Not many studies are available regarding the improvement in hearing loss after giving oral corticosteroids.

•Hence, this study is planned to assess the improvement in hearing loss and side effects after giving intratympanic dexamethasone and oral deflazacort.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with sudden SNHL for the first time (duration less than or equal to 7 days).
  • Patients with age group 18-65 years.

排除标准

  • 未提供

结局指标

主要结局

To compare the improvement of hearing by intratympanic dexamethasone versus oral deflazacort in sudden sensorineural hearing loss (SSNHL).

时间窗: 1 week & 3 weeks

次要结局

  • To compare the tolerability & side effects of intratympanic dexamethasone & oral deflazacort in patients under treatment for sudden sensorineural hearing loss.

研究者

发起方
DR LIPSY
申办方类型
Other [Dr Lipsy]
责任方
Principal Investigator
主要研究者

LIPSY

KALINGA INSTITUTE OF MEDICAL SCIENCES, BHUBANESWAR, ODISHA

研究点 (1)

Loading locations...

相似试验